QSIAW
Quantum-Si incorporated
Price Chart
Latest Quote
$0.01
Current Price| Open | $0.44 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 166,656 |
Stock Information
| Total Debt | $3.71M |
| Cash Equivalents | $127.34M |
| Revenue | $1.85M |
| Net Income | $-103.82M |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Sales | $1.85M |
| Income | $-103.82M |
| Book/sh | $0.92 |
| Employees | 145 |
Financial Ratios
| Quick Ratio | 11.91 |
| Current Ratio | 12.60 |
| Debt/Eq | 1.85 |
Returns & Margins
| ROA | -24.76% |
| ROE | -46.38% |
| Gross Margin | 40.01% |
| Operating Margin | -9322.87% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.01 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.20 |
| SMA50 | $0.20 |
| RSI | nan |
| Shares Float | 179.33M |
| Volatility | 3.17 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| YTD | +35.65% |
| 10 Years | +35.65% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.20 | 0 |
| 2026-06-17 | $0.20 | 0 |
| 2026-06-16 | $0.20 | 0 |
| 2026-06-15 | $0.20 | 0 |
| 2026-06-12 | $0.20 | 0 |
| 2026-06-11 | $0.20 | 0 |
| 2026-06-10 | $0.20 | 0 |
| 2026-06-09 | $0.20 | 0 |
| 2026-06-08 | $0.20 | 0 |
| 2026-06-05 | $0.20 | 0 |
| 2026-06-04 | $0.20 | 0 |
| 2026-06-03 | $0.20 | 0 |
| 2026-06-02 | $0.20 | 0 |
| 2026-06-01 | $0.20 | 0 |
| 2026-05-29 | $0.20 | 0 |
| 2026-05-28 | $0.20 | 0 |
| 2026-05-27 | $0.20 | 0 |
| 2026-05-26 | $0.20 | 0 |
| 2026-05-22 | $0.20 | 0 |
| 2026-05-21 | $0.20 | 0 |
| 2026-05-20 | $0.20 | 0 |
| 2026-05-19 | $0.20 | 0 |
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
đ° Latest News
Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?
Simply Wall St. âĸ 2026-05-31T12:17:05Z
Quantum-Si Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-08T22:13:26Z
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-07T23:05:18Z
Quantum-Si (QSI) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-07T22:46:11Z
Quantum-Si incorporated's (NASDAQ:QSI) 21% loss last week hit both individual investors who own 49% as well as institutions
Simply Wall St. âĸ 2025-11-10T16:42:42Z
Quantum-Si Inc (QSI) Q3 2025 Earnings Call Highlights: Innovation Milestones Amid Revenue Challenges
GuruFocus.com âĸ 2025-11-06T05:05:40ZQuantum-Si Incorporated (QSI) Reports Q3 Loss, Lags Revenue Estimates
Zacks âĸ 2025-11-06T00:50:01Z
Quantum-Si (QSI): Evaluating Valuation After $300 Million Shelf Registration Sparks Investor Debate
Simply Wall St. âĸ 2025-10-14T16:11:30Z
Why Quantum-Si Stock Flopped on Friday
Motley Fool âĸ 2025-10-10T20:35:00Z
Will Quantum-Si's (QSI) Dual Shelf Offerings Reshape Its Funding Flexibility or Signal Cautious Optimism?
Simply Wall St. âĸ 2025-10-06T12:22:50Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,283,000 | $1,458,000 | $594,000 | $0 |
| Cost Of Revenue | $1,283,000 | $1,458,000 | $594,000 | $0 |
| Total Revenue | $2,436,000 | $3,058,000 | $1,082,000 | $0 |
| Operating Revenue | $2,436,000 | $3,058,000 | $1,082,000 | $0 |
| Expenses | ||||
| Total Expenses | $99,796,000 | $111,634,000 | $112,253,000 | $114,358,000 |
| Other Income Expense | $-12,885,000 | $-2,013,000 | $14,752,000 | $-18,084,000 |
| Other Non Operating Income Expenses | $955,000 | $-19,000 | $366,000 | $458,000 |
| Net Non Operating Interest Income Expense | $8,964,000 | $9,638,000 | $459,000 | $0 |
| Operating Expense | $98,513,000 | $110,176,000 | $111,659,000 | $114,358,000 |
| Interest Expense | - | - | $0 | $0 |
| Interest Expense Non Operating | - | - | $0 | $0 |
| Selling And Marketing Expense | - | - | - | - |
| General And Administrative Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Net Interest Income | $8,964,000 | $9,638,000 | $459,000 | $0 |
| Interest Income | $8,964,000 | $9,638,000 | $459,000 | - |
| Normalized Income | $-90,405,400 | $-99,431,740 | $-110,346,000 | $-113,900,000 |
| Net Income From Continuing And Discontinued Operation | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Total Operating Income As Reported | $-116,099,000 | $-108,576,000 | $-111,171,000 | $-123,841,000 |
| Net Income Common Stockholders | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Net Income | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Net Income Including Noncontrolling Interests | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Net Income Continuous Operations | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Pretax Income | $-101,281,000 | $-100,951,000 | $-95,960,000 | $-132,442,000 |
| Special Income Charges | $-18,739,000 | $0 | $0 | $-9,483,000 |
| Interest Income Non Operating | $8,964,000 | $9,638,000 | $459,000 | - |
| Operating Income | $-97,360,000 | $-108,576,000 | $-111,171,000 | $-114,358,000 |
| Gross Profit | $1,153,000 | $1,600,000 | $488,000 | $0 |
| Other | ||||
| Tax Effect Of Unusual Items | $-2,906,400 | $-418,740 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-79,066,000 | $-101,982,000 | $-121,401,000 | $-93,232,000 |
| Total Unusual Items | $-13,840,000 | $-1,994,000 | $14,386,000 | $-18,542,000 |
| Total Unusual Items Excluding Goodwill | $-13,840,000 | $-1,994,000 | $14,386,000 | $-18,542,000 |
| Reconciled Depreciation | $4,454,000 | $4,600,000 | $4,156,000 | $2,584,000 |
| EBITDA (Bullshit earnings) | $-92,906,000 | $-103,976,000 | $-107,015,000 | $-111,774,000 |
| EBIT | $-97,360,000 | $-108,576,000 | $-111,171,000 | $-114,358,000 |
| Diluted NI Availto Com Stockholders | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Tax Provision | $58,000 | $56,000 | $0 | $0 |
| Other Special Charges | $18,739,000 | - | - | - |
| Gain On Sale Of Security | $4,899,000 | $-1,994,000 | $14,386,000 | $-9,059,000 |
| Research And Development | $53,759,000 | $59,641,000 | $67,025,000 | $72,062,000 |
| Selling General And Administration | $44,754,000 | $50,535,000 | $44,634,000 | $42,296,000 |
| Impairment Of Capital Assets | - | $0 | $0 | $9,483,000 |
| Other Gand A | - | - | - | - |
Fetched: 2026-06-08
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $220,226,000 | $215,420,000 | $271,087,000 | $358,706,000 |
| Total Assets | $245,607,000 | $247,871,000 | $298,250,000 | $391,485,000 |
| Total Non Current Assets | $69,747,000 | $29,862,000 | $31,940,000 | $33,303,000 |
| Other Non Current Assets | $234,000 | $808,000 | $695,000 | $697,000 |
| Investmentin Financial Assets | $52,855,000 | $0 | - | - |
| Current Assets | $175,860,000 | $218,009,000 | $266,310,000 | $358,182,000 |
| Other Current Assets | $4,554,000 | $3,006,000 | $4,261,000 | $6,873,000 |
| Inventory | $3,197,000 | $4,067,000 | $3,945,000 | $0 |
| Receivables | $5,199,000 | $1,333,000 | $368,000 | $0 |
| Other Receivables | $4,638,000 | - | - | - |
| Accounts Receivable | $561,000 | $1,333,000 | $368,000 | $0 |
| Allowance For Doubtful Accounts Receivable | $-270,000 | $-124,000 | $0 | $0 |
| Gross Accounts Receivable | $831,000 | $1,457,000 | $368,000 | $0 |
| Cash Cash Equivalents And Short Term Investments | $162,910,000 | $209,603,000 | $257,736,000 | $351,309,000 |
| Cash And Cash Equivalents | $21,639,000 | $49,241,000 | $133,860,000 | $84,319,000 |
| Goodwill And Other Intangible Assets | - | $0 | $532,000 | $0 |
| Other Intangible Assets | - | - | $532,000 | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $4,166,000 | $12,948,000 | $15,303,000 | $17,446,000 |
| Long Term Debt And Capital Lease Obligation | $2,322,000 | $9,250,000 | $13,737,000 | $16,077,000 |
| Current Debt And Capital Lease Obligation | $1,844,000 | $3,698,000 | $1,566,000 | $1,369,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $25,381,000 | $32,451,000 | $26,631,000 | $32,779,000 |
| Total Non Current Liabilities Net Minority Interest | $2,356,000 | $14,264,000 | $15,022,000 | $17,073,000 |
| Other Non Current Liabilities | $34,000 | $19,000 | $11,000 | - |
| Derivative Product Liabilities | $0 | $4,995,000 | $1,274,000 | $996,000 |
| Current Liabilities | $23,025,000 | $18,187,000 | $11,609,000 | $15,706,000 |
| Other Current Liabilities | $1,068,000 | $325,000 | $187,000 | $88,000 |
| Current Deferred Liabilities | $133,000 | $189,000 | - | - |
| Payables And Accrued Expenses | $19,980,000 | $13,975,000 | $9,856,000 | $14,249,000 |
| Payables | $2,172,000 | $3,270,000 | $1,773,000 | $3,903,000 |
| Total Tax Payable | $549,000 | $1,339,000 | $7,000 | - |
| Accounts Payable | $1,623,000 | $1,931,000 | $1,766,000 | $3,903,000 |
| Equity | ||||
| Common Stock Equity | $220,226,000 | $215,420,000 | $271,619,000 | $358,706,000 |
| Total Equity Gross Minority Interest | $220,226,000 | $215,420,000 | $271,619,000 | $358,706,000 |
| Stockholders Equity | $220,226,000 | $215,420,000 | $271,619,000 | $358,706,000 |
| Gains Losses Not Affecting Retained Earnings | $-6,000 | $45,000 | $0 | - |
| Other Equity Adjustments | $-6,000 | $45,000 | - | - |
| Retained Earnings | $-697,980,000 | $-596,641,000 | $-495,634,000 | $-399,674,000 |
| Other | ||||
| Ordinary Shares Number | $216,368,773 | $166,890,771 | $141,769,917 | $139,944,257 |
| Share Issued | $216,368,773 | $166,890,771 | $141,769,917 | $139,944,257 |
| Tangible Book Value | $220,226,000 | $215,420,000 | $271,087,000 | $358,706,000 |
| Invested Capital | $220,226,000 | $215,420,000 | $271,619,000 | $358,706,000 |
| Working Capital | $152,835,000 | $199,822,000 | $254,701,000 | $342,476,000 |
| Capital Lease Obligations | $4,166,000 | $12,948,000 | $15,303,000 | $17,446,000 |
| Total Capitalization | $220,226,000 | $215,420,000 | $271,619,000 | $358,706,000 |
| Additional Paid In Capital | $918,190,000 | $811,998,000 | $767,239,000 | $758,366,000 |
| Capital Stock | $22,000 | $18,000 | $14,000 | $14,000 |
| Common Stock | $22,000 | $18,000 | $14,000 | $14,000 |
| Long Term Capital Lease Obligation | $2,322,000 | $9,250,000 | $13,737,000 | $16,077,000 |
| Current Deferred Revenue | $133,000 | $189,000 | - | - |
| Current Capital Lease Obligation | $1,844,000 | $3,698,000 | $1,566,000 | $1,369,000 |
| Current Accrued Expenses | $17,808,000 | $10,705,000 | $8,083,000 | $10,346,000 |
| Investments And Advances | $52,855,000 | $0 | - | - |
| Available For Sale Securities | $52,855,000 | - | - | - |
| Net PPE | $16,658,000 | $29,054,000 | $30,713,000 | $32,606,000 |
| Accumulated Depreciation | $-16,737,000 | $-11,707,000 | $-10,043,000 | $-6,203,000 |
| Gross PPE | $33,395,000 | $40,761,000 | $40,756,000 | $38,809,000 |
| Leases | $11,790,000 | $7,226,000 | $6,948,000 | $1,308,000 |
| Construction In Progress | $1,390,000 | $4,960,000 | $2,438,000 | $6,234,000 |
| Other Properties | $18,079,000 | $26,473,000 | $29,165,000 | $29,788,000 |
| Machinery Furniture Equipment | $2,136,000 | $2,102,000 | $2,205,000 | $1,479,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $950,000 | $565,000 | $1,558,000 | $0 |
| Work In Process | $1,794,000 | $2,212,000 | $779,000 | $0 |
| Raw Materials | $453,000 | $1,290,000 | $1,608,000 | $0 |
| Other Short Term Investments | $141,271,000 | $160,362,000 | $123,876,000 | $266,990,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | - | $5,548,000 |
| Goodwill | - | - | - | $0 |
| Preferred Stock | - | - | - | - |
Fetched: 2026-06-08
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-97,234,000 | $-92,437,000 | $-99,309,000 | $-101,301,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-94,717,000 | $-87,795,000 | $-94,036,000 | $-90,560,000 |
| Cash Flow From Continuing Operating Activities | $-94,717,000 | $-87,795,000 | $-94,036,000 | $-90,560,000 |
| Operating Gains Losses | $-4,171,000 | $4,146,000 | $5,517,000 | $-1,711,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,517,000 | $-4,642,000 | $-5,273,000 | $-10,741,000 |
| Investing Cash Flow | $-28,320,000 | $-32,675,000 | $143,428,000 | $137,185,000 |
| Cash Flow From Continuing Investing Activities | $-28,320,000 | $-32,675,000 | $143,428,000 | $137,185,000 |
| Capital Expenditure Reported | $0 | $-59,000 | $-763,000 | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $93,510,000 | $34,789,000 | $0 | $0 |
| Financing Cash Flow | $95,423,000 | $35,876,000 | $149,000 | $1,909,000 |
| Cash Flow From Continuing Financing Activities | $95,423,000 | $35,876,000 | $149,000 | $1,909,000 |
| Net Common Stock Issuance | $93,510,000 | $34,789,000 | $0 | $0 |
| Common Stock Issuance | $93,510,000 | $34,789,000 | $0 | $0 |
| Net Other Financing Charges | - | $14,000 | $-208,000 | $-848,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $24,000 | $0 | $0 | - |
| End Cash Position | $21,639,000 | $49,241,000 | $133,860,000 | $84,319,000 |
| Beginning Cash Position | $49,241,000 | $133,860,000 | $84,319,000 | $35,785,000 |
| Effect Of Exchange Rate Changes | $12,000 | $-25,000 | $0 | $0 |
| Changes In Cash | $-27,614,000 | $-84,594,000 | $49,541,000 | $48,534,000 |
| Proceeds From Stock Option Exercised | $1,913,000 | $1,073,000 | $357,000 | $2,757,000 |
| Net Investment Purchase And Sale | $-25,803,000 | $-28,033,000 | $148,701,000 | $147,926,000 |
| Sale Of Investment | $378,778,000 | $341,400,000 | $272,510,000 | $148,760,000 |
| Purchase Of Investment | $-404,581,000 | $-369,433,000 | $-123,809,000 | $-834,000 |
| Net PPE Purchase And Sale | $-2,517,000 | $-4,583,000 | $-4,510,000 | $-10,741,000 |
| Purchase Of PPE | $-2,517,000 | $-4,583,000 | $-4,510,000 | $-10,741,000 |
| Change In Working Capital | $-4,578,000 | $4,643,000 | $-3,195,000 | $3,053,000 |
| Change In Other Current Liabilities | $-3,167,000 | $-3,394,000 | $-2,136,000 | $9,368,000 |
| Change In Other Current Assets | $-4,635,000 | $-113,000 | $-81,000 | $-7,000 |
| Change In Payables And Accrued Expense | $6,167,000 | $4,411,000 | $-3,055,000 | $-5,303,000 |
| Change In Accrued Expense | $6,505,000 | $4,021,000 | $-1,835,000 | $-6,024,000 |
| Change In Payable | $-338,000 | $390,000 | $-1,220,000 | $721,000 |
| Change In Account Payable | $-338,000 | $390,000 | $-1,220,000 | $721,000 |
| Change In Prepaid Assets | $-1,563,000 | $486,000 | $2,159,000 | $-1,005,000 |
| Change In Inventory | $-2,006,000 | $4,342,000 | $286,000 | $0 |
| Change In Receivables | $626,000 | $-1,089,000 | $-368,000 | $0 |
| Changes In Account Receivables | $626,000 | $-1,089,000 | $-368,000 | $0 |
| Other Non Cash Items | $5,730,000 | $2,446,000 | $1,002,000 | $1,105,000 |
| Stock Based Compensation | $10,773,000 | $8,887,000 | $8,516,000 | $11,206,000 |
| Unrealized Gain Loss On Investment Securities | $0 | $0 | $-10,690,000 | $16,162,000 |
| Provisionand Write Offof Assets | $146,000 | $124,000 | $0 | $0 |
| Asset Impairment Charge | $2,290,000 | $-3,229,000 | $-3,382,000 | $9,483,000 |
| Amortization Of Securities | $-8,022,000 | $-8,405,000 | $0 | $0 |
| Depreciation Amortization Depletion | $4,454,000 | $4,600,000 | $4,156,000 | $2,584,000 |
| Depreciation And Amortization | $4,454,000 | $4,600,000 | $4,156,000 | $2,584,000 |
| Gain Loss On Investment Securities | $-4,202,000 | $3,721,000 | $5,381,000 | $-1,802,000 |
| Gain Loss On Sale Of PPE | $31,000 | $425,000 | $136,000 | $91,000 |
| Net Income From Continuing Operations | $-101,339,000 | $-101,007,000 | $-95,960,000 | $-132,442,000 |
| Repayment Of Debt | - | - | $0 | $0 |
| Net Issuance Payments Of Debt | - | - | $0 | $0 |
| Net Long Term Debt Issuance | - | - | $0 | $0 |
| Long Term Debt Payments | - | - | $0 | $0 |
| Net Business Purchase And Sale | - | - | $0 | $0 |
| Purchase Of Business | - | - | $0 | $0 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Depreciation | - | - | - | - |
Fetched: 2026-06-08